CorMedix Inc. (CRMD) vs CytomX Therapeutics, Inc. (CTMX)
A side-by-side comparison of CorMedix Inc. and CytomX Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRMD
CorMedix Inc.
$7.19HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
CTMX
CytomX Therapeutics, Inc.
$2.54HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — CRMD vs CTMX
growth of $100 · dividends reinvested · last 10yCRMD -48.3% (-6.4%/yr)CTMX -83.1% (-16.3%/yr)CRMD compounded faster over this window
CRMD CTMX
CRMD vs CTMX: by the numbers
- •CRMD is the larger company ($564M vs $554M market cap).
- •CRMD is profitable (40.49% net margin) while CTMX runs a net loss (-435.21%).
- •CRMD grew revenue faster over the past five years (352.03% vs 2.18% CAGR).
Metrics side by side
Valuation
| Metric | CRMD | CTMX |
|---|---|---|
| P/E ratio | 3.37 | N/A |
| Forward P/E | 14.52 | N/A |
| P/S ratio | 1.22 | 30.25 |
| P/B ratio | 1.22 | 1.83 |
| EV / EBITDA | 1.79 | N/A |
| FCF yield | 44.38% | N/A |
Profitability
| Metric | CRMD | CTMX |
|---|---|---|
| Gross margin | 82.78% | 98.63% |
| Operating margin | 46.95% | -29.35% |
| Net margin | 40.49% | -435.21% |
| ROE | 40.62% | -26.37% |
| ROIC | 27.87% | -25.42% |
Growth (annualized)
| Metric | CRMD | CTMX |
|---|---|---|
| Revenue CAGR (5Y) | 352.03% | 2.18% |
| Total return CAGR (5Y) | 9.70% | -12.01% |
Frequently asked
- Which has grown faster, CRMD or CTMX?
- Over the past five years, CRMD grew revenue faster — CRMD at a 352.03% CAGR versus CTMX at 2.18%.
- Is CRMD or CTMX more profitable?
- CRMD runs the higher net margin — CRMD at 40.49% versus CTMX at -435.21%.
- How have CRMD and CTMX total returns compared?
- Over the past 10 years, CRMD delivered -7.74% and CTMX delivered -16.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CorMedix P/E ratioCorMedix ROECytomX Therapeutics ROECorMedix operating marginCytomX Therapeutics operating marginCorMedix revenue growthCytomX Therapeutics revenue growthCorMedix free cash flowCytomX Therapeutics free cash flow
CorMedix & CytomX Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.